Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
In the Clinic Episode 57: Fibromyalgia
BS Medicine Episode #619: Scan, See, Decide: POCUS in the Evaluation of Dyspnea
In the Clinic Episode 56: Fatigue, Part II
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D








Please provide any additional comments (optional).